Unlike in other tumour sites such as non-small cell lung cancer (NSCLC) and melanoma, tissue programmed death-ligand 1 (PD-L1) score does not appear to be a reliable predictive biomarker of response6. The gene discussed is CD274; the disease is non-small cell lung carcinoma.